Cargando…
Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction
Sorafenib is a multi-targeted kinase inhibitor, which is the current standard treatment for advanced hepatocellular carcinoma (HCC). Only one case of radiation recall dermatitis (RRD) associated with sorafenib has been reported so far. Our patient with recurrent HCC was treated with palliative radio...
Autores principales: | Oh, Dongryul, Park, Hee Chul, Lim, Ho Yeong, Yoo, Byung Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Radiation Oncology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797277/ https://www.ncbi.nlm.nih.gov/pubmed/24137563 http://dx.doi.org/10.3857/roj.2013.31.3.171 |
Ejemplares similares
-
Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma
por: Kim, Gwi Eon, et al.
Publicado: (2017) -
Radiation Recall Dermatitis in Patients Treated with Sorafenib
por: Mehta, Keyur, et al.
Publicado: (2018) -
Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy
por: Hsieh, Chen-Hsi, et al.
Publicado: (2014) -
Sorafenib-Induced Acute Generalized Exanthematous Pustulosis
por: Cortese, Andrea, et al.
Publicado: (2023) -
Nitrofurantoin-induced radiation recall dermatitis
por: Garrahy, Ian, et al.
Publicado: (2019)